SavedAdd your journal

Journals / Medicine Science / 2021 / Cilt: 10 - Sayı: 4

Comparison of the algan hemostatic agent with celox in rat femoral artery bleeding model

Abdullah Canberk Ozbaykus
Ali Kumandas
Kenan Binnetoglu
Husamettin Ekici
Mehmet Tiryaki
Pages
1469–1473
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to the results, there was no difference in bleeding control between AHA and C (p>0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The most important reasons of deaths after a trauma are major vascular injury.
📊
Key Findings & Data:A total of 28 wistar albino rats divided into 4 equal groups.
💡
Conclusion & Impact:According to the results, there was no difference in bleeding control between AHA and C (p>0.05).
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The most important reasons of deaths after a trauma are major vascular injury. The effective and speedy control of the hemorrhage is crucial in reducing such deaths. Although many products are being used for this topic, most effective products have not yet been developed currently, and there is an urgent need for effective hemostatic. The aim of this study is to compare the efficacy of Algan hemostatic agent (AHA) with Celox in femoral artery incision model in rats. A total of 28 wistar albino rats divided into 4 equal groups. Experimental femoral artery injury was inflicted. In the control group, saline impregnated gauze was employed. AHA impregnated sponge, AHA powder, and Celox in powder form were utilized in the experimental groups. According to the results, there was no difference in bleeding control between AHA and C (p>0.05). When compared to the control group, AHA and Celox were found to be very effective in bleeding control (p

🔖

Cite This Article

Ozbaykus, A. C., Kumandas, A., Binnetoglu, K., Ekici, H., Tiryaki, M. (2022). Comparison of the algan hemostatic agent with celox in rat femoral artery bleeding model. Medicine Science, Cilt: 10 - Sayı: 4, 1469–1473. https://ajindex.com/articles/579651

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma Acute Care Surg. 1995;38:185-193
  2. Champion HR, Bellamy RF, Roberts CP, et al. A profile of combat injury. J Trauma Acute Care Surg. 2003;54:13-19
  3. Carson J, Spence R, Poses R, et al. Severity of anaemia and operative mortality and morbidity. Lancet. 1988;331:727-9
  4. Wu WC, Trivedi A, Friedmann PD, et al. Association between hospital intraoperative blood transfusion practices for surgical blood loss and hospital surgical mortality rates. Ann surg. 2012;255:708-14
  5. Huri E, Akgül KT, Yücel MÖ, Aet al. The second step in vitro trial of Ankaferd® Bloodstopper®: comparison with other hemostatic agents. Turk J Med Sci. 2011;41:7-15
  6. Hanks JB, Kjaergard HK, Hollingsbee DA. A comparison of the haemostatic effect of Vivostat® patient-derived fibrin sealant with oxidised cellulose (Surgicel®) in multiple surgical procedures. Eur Surg Res. 2003;35:439- 444 7. Aydinoglu A, Ersoy G, Dogan A, et al. Hemostatic effect of microporous polysaccharide hemosphere in a heparinized rat model with femoral artery bleeding. Eur J Emerg Med. 2008;15:286–306
  7. Akarsu C, Kalaycı MU, Yavuz E,et el. Comparison of the hemostatic efficiency of Ankaferd Blood Stopper and fibrin glue on a liver laceration model in rats. Ulus Travma Acil Cerrahi Derg. 2011;17:308-12
  8. Jackson MR. New and potential uses of fibrin sealants as an adjunct to surgical hemostasis. Am j surg 2001;182:36-9
  9. Abacıoğlu S, Aydın K, Büyükcam F, et al. Comparison of the efficiencies of buffers containing Ankaferd and Chitosan on hemostasis in an experimental rat model with femoral artery bleeding. Turk J Hematol. 2016;33: 48.-52
  10. Ersoy G, Kaynak, MF, Yilmaz O, et al. Hemostatic effects of microporous polysaccharide hemosphere® in a rat model with severe femoral artery bleeding. Adv ther. 2007;24:485-92
  11. Aktop S, Emekli-Alturfan E, Ozer C, et al. Effects of Ankaferd Blood Stopper and Celox on the tissue factor activities of warfarin-treated rats. Clin Appl Thromb Hemost. 2014;20:16-21
  12. Ozgur D, Gurkan E, Osman Y, et al. The effect of application of local oxidised cellulose powder on hemostasis time in a rat model with femoral artery bleeding. Acta Med Mediterr. 2015;31:179–82
  13. Sabatini L, Trecci A, Imariso D, et al. Fibrin tissue adhesive reduces postoperative blood loss in total knee arthroplasty. J Orthop Trauma. 2012; 13:145-51
  14. Echave M, Oyagüez I, Casado MA. Use of Floseal®, a huma